SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000930413-20-000363
Filing Date
2020-02-14
Accepted
2020-02-14 10:22:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 c95259_sc13ga.htm SC 13G/A 45939
  Complete submission text file 0000930413-20-000363.txt   47536
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
Type: SC 13G/A | Act: 34 | File No.: 005-86436 | Film No.: 20615201
SIC: 2834 Pharmaceutical Preparations

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

IRS No.: 010786483 | State of Incorp.: DE
Type: SC 13G/A